Celera Genomics Teams With GE To Develop Cancer Imaging Agents
This article was originally published in The Gray Sheet
Executive Summary
GE Global Research will assume responsibility for the regulation and manufacture of imaging agents to be jointly developed with Celera Genomics
You may also be interested in...
People In Brief
FDA external relations: Agency names Mayer, Brown, Rowe & Maw attorney Sheila Walcoff to succeed Peter Pitts as associate commissioner for external relations (1"The Gray Sheet" June 28, 2004, p. 4). In her new role, Walcoff will advise Acting Commissioner Lester Crawford on legal policy and program direction for FDA's interactions with stakeholders and other external audiences, as well as supervise the agency's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues and the Advisory Committee Oversight and Management Staff. Lawrence Bachorik, who had been filling in for Pitts, will return to his role as FDA assistant commissioner for public affairs...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.